COVID-19 IN INFLAMMATORY BOWEL DISEASE: SHOULD WE BE MORE CAREFUL WITH THE USE OF SALICYLATES?
Mariana Rolim Fernandes MacedoCarlos Arthur Fernandes SobreiraCarola Braz de LavorCamila Ribeiro RôlaTiciana Maria de Lavor RolimFrancisco Sérgio Rangel de Paula PessoaMilena Santana GirãoCaio Cesar Furtado FreireRanna Caroline Bezerra SiebraIsabele de Sá Silveira MeloMarcellus Henrique Loiola Ponte de SouzaLúcia Libanez Bessa Campelo BragaLiana Perdigão MelloDébora Bezerra SilvaLuís Arthur Brasil Gadelha FariasMaura Salaroli de OliveiraLauro Vieira Perdigão NetoAnna Sara LevinPublished in: Arquivos de gastroenterologia (2024)
IBD patients at high risk of COVID-19 infection may need to avoid salicylate therapy but further studies are necessary to confirm this association.